Clinical Trial Update: TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCT [Phase 2]

View source ↗

Summary

Phase 2 randomized trial investigating temozolomide plus apatinib in newly diagnosed high-grade glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma
• High-grade Glioma

Drugs mentioned

• Apatinib (apatinib)
• Temozolomide (Temozolomide)

Snippet

Sponsor: The Second Hospital of Hebei Medical University | Conditions: Glioma | Phase 2 | Status: UNKNOWN